By Zachary Stieber
There is plenty of evidence that people who have recovered from COVID-19 have natural protection against reinfection, Rep. Diana Harshbarger (R-Tenn.) said.
“There’s ample scientific studies that show that natural immunity is absolutely one of the best things you could have—and some studies even show that it’s more effective than vaccination,” Harshbarger said during a recent appearance on NTD’s “Capitol Report.”Play Video
Natural immunity refers to post-recovery antibodies that shield an individual against reinfection by the CCP (Chinese Communist Party) virus, which causes COVID-19.
Multiple studies have indicated that natural immunity among past COVID-19 patients is strong and similar or superior to the protection gained from COVID-19 vaccines. Some experts have pushed for federal health officials to take natural immunity into account when issuing recommendations and rules. But federal authorities currently recommend that virtually everybody be vaccinated, including those who have recovered, arguing that the strong protection gets even better when those people get the shot.
Harshbarger says a number of Americans have objections to getting the vaccine, while pointing out that natural immunity to other diseases is accepted as an alternative.
She and 10 other members of the House of Representatives late last week introduced the “Natural Immunity Is Real Act,” a companion to a Senate bill from Sens. Mike Lee (R-Utah), Tommy Tuberville (R-Ala.), Mike Braun (R-Ind.), and Dan Sullivan (R-Alaska).
It would require federal agencies to “acknowledge, accept, and agree to truthfully present, natural immunity pertaining to COVID-19 pursuant to promulgating certain regulations.”
The lawmakers are presenting the proposal as President Joe Biden’s administration works to finalize a regulation that would force private companies with over 100 employees to mandate presenting proof of COVID-19 vaccination or have staff members be tested weekly for the disease. There is no opt-out for natural immunity.
Other mandates are already in place on the federal, state, and local levels that have led to some Americans losing their jobs.
Harshbarger, a licensed pharmacist since 1987, said: “I’ve read some of the studies that show that natural immunity, in a lot of ways, can be more effective. And I know there’s one study that shows that the percentage of protection is even better than two doses of the vaccine, in some cases. There is ample scientific data out there that show that. Think about it. We have immunity against measles, and smallpox, and they accept that. Why won’t they do it for COVID?”
Rep. Daniel Webster (R-Fla.) said in a statement: “Too many medical leaders are refusing to publicly recognize what overwhelming data has already shown—protection afforded to individuals with natural immunity is real, robust and durable. Denying science only contributes to existing confusion, misinformation, and mistrust among the American people. This bill helps restore trust and faith in the Public Health system, while maintaining our fight against COVID-19.”
The other co-sponsors are Reps. Jeff Van Drew (R-N.J.), Chris Stewart (R-Utah), Bill Posey (R-Fla.), Mary Miller (R-Ind.), Mariannette Miller-Meeks (R-Iowa), Dan Bishop (R-N.C.), Mo Brooks (R-Ala.), Madison Cawthorn (R-N.C.), and Chip Roy (R-Texas).
- Gold Is Outperforming Bitcoin and the Stock Market in the Past 3 Months: What’s the Better Hedge?
- Growing Number of European Countries Rolling Back COVID-19 Restrictions
- Baltic Nations Send US-Made Weapons to Ukraine Amid Russian Threat
- US Now Requires All Foreign Travelers to Be COVID-19 Vaccinated When Crossing Land Ports, Ferry Terminals
- Biden’s COVID-19 Vaccine Mandate for Federal Workers Blocked Nationwide
- Vermont Woman Fired, Denied Unemployment for Refusing Vaccine, Becomes Homeless and Flees to Florida on
- Trump Promises ‘Orderly Transition’ After Biden Certified as President-Elect on
- Trump Says Supreme Court ‘Incompetent and Weak’ Over Election Fraud on
- NH’s Voting Machines Are Capable of Redistributing Votes on
- Dominion’s Parent Company Arranges $400 Million Placement 1 Month Before Election: SEC Filing on